NYSE : DVA

DaVita Inc.

$236.31 USD

$0.87 (0.37%)

Volume
597.04K
Average Volume
875.31K
Market Capitalization
$15.17B
P/E Ratio
23.28
Dividend Yield
0.00%
Price Target
$235.00
Year High
$239.64
Year Low
$101.00
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.42
Company Overview

NYSE

Javier J. Rodriguez

Medical - Care Facilities

Healthcare

DVA

78000

US

USD

https://www.davita.com

720 631 2100

23918K108

0000927066

Liquidity Metrics

-17.50

1.42

1.37

0.25

0.00

Sales & Valuation

$13.64B

1.10

-21.08

10.16

22.15

Profitability

$9.51

$746.8M

5.65%

10.13%

-133.12%

4.47%

P/E Metrics

23.28

-12.05

-12.05

Analyst Price Target & Rating

$235.00

$270.00

$218.00

Sell

2/5

23 Analysts

0.56%

Financial Health Scores

1.78

8/9

$1.2B

$17.5B

$16.45B

$1.98B

Key Metrics (TTM)

$27.61B

2.00

10.23

1.42

-133.12%

10.70%

4.93%

9.88%

57 days

Company Executives
Name Title
Christopher Michael Berry Group Vice President & Chief Accounting Officer
Jeffrey Allen Giullian Chief Medical Officer of Kidney Care
Partha Das Chief Medical Officer of DaVita International
David Maughan Chief Operating Officer of DaVita Kidney Care
Kathleen Alyce Waters Chief Legal & Public Affairs Officer
Stephanie Hendrickson Chief People Officer
Nic Eliason Group Vice President of Investor Relations
Misha Palecek Chief Transformation Officer of U.S. Kidney Care Business
James O. Hearty Chief Compliance Officer
Javier J. Rodriguez Chief Executive Officer & Executive Director
Joel Ackerman Chief Financial Officer & Treasurer
Poll Results

No votes yet today — be the first to share your view!

About DaVita Inc. (NYSE:DVA) Stock

DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic laboratories, performing routine tests vital for dialysis patients, alongside other physician-ordered laboratory analyses specifically for those with end-stage renal disease (ESRD). The firm also offers administrative and management support to various other outpatient dialysis facilities. Its broad spectrum of offerings extends to chronic disease management programs, supporting a substan ... tial patient cohort; by year-end 2021, this included 16,000 patients enrolled in risk-based integrated care models and an additional 7,000 in other integrated care arrangements. Further specialized services encompass vascular access interventions, clinical research initiatives, direct physician support, and a complete suite of holistic kidney care solutions. As of December 31, 2021, DaVita's footprint across the United States comprised 2,815 outpatient dialysis centers, collectively serving approximately 203,100 patients. Globally, the company operated 339 outpatient dialysis centers spread across ten countries outside the U.S., attending to roughly 39,900 patients. Moreover, it furnished acute inpatient dialysis services and related laboratory work in around 850 U.S. hospitals. Founded in 1994, DaVita Inc. maintains its headquarters in Denver, Colorado. The company rebranded to its current name in September 2016, having previously been known as DaVita HealthCare Partners Inc.

DaVita Inc. Schedules 2nd Quarter 2026 Investor Conference Call

2026-07-21 17:00:00

DENVER, July 21, 2026 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, August 4, 2026, at 5:00 p.m. Eastern Time.

DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors

2026-07-17 19:01:05

DaVita HealthCare (DVA) reached $236.97 at the closing of the latest trading day, reflecting a +1.26% change compared to its last close.

DaVita HealthCare (DVA) Rises As Market Takes a Dip: Key Facts

2026-07-16 19:16:06

In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $234.01, denoting a +1.04% move from the preceding trading day.

DaVita: I Believe This Is Overvalued

2026-07-15 12:14:30

DaVita Inc. has more than doubled in share price within six months, driven by a strong Q1 '26 beat and a favorable court ruling. DVA fundamentals and long-term prospects remain largely unchanged, with 2026E AEPS recovery now expected at 30%+ and 10–16% annualized growth through 2028. I sold over 95% of my DVA position as the valuation exceeded $210/share, far above my fair value target of $130/share.

DaVita HealthCare (DVA) Laps the Stock Market: Here's Why

2026-07-10 19:01:08

In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $232.8, denoting a +1.45% move from the preceding trading day.

Everyone Is Watching Greg Abel. But Another Berkshire Hathaway Stock Picker Is Quietly Winning in 2026.

2026-07-09 18:30:00

Greg Abel may have taken over as CEO, but he's not the only one making key investment decisions at Berkshire Hathaway. Berkshire's positions in DaVita and SiriusXM, reportedly selected by Ted Weschler, who manages a portion of the portfolio, have outperformed so far in 2026.

DaVita HealthCare (DVA) Suffers a Larger Drop Than the General Market: Key Insights

2026-07-08 19:16:06

DaVita HealthCare (DVA) reached $230.72 at the closing of the latest trading day, reflecting a -1.53% change compared to its last close.

Top 5 Non-AI S&P 500 Stock Picks for 2H 2026 That Have Surged in 1H

2026-07-03 09:55:53

ADM, CASY, DVA, CVS and BEN top a list of five non-AI S&P 500 stocks that surged more than 30% in 1H 2026 and still show momentum for 2H.

Frequently Asked Questions

What is the current DaVita Inc. (DVA) stock price?

DaVita Inc.(NYSE:DVA) stock price is $236.31 in the last trading session. During the trading session, DVA stock reached the peak price of $239.64 while $101 was the lowest point it dropped to. The percentage change in DVA stock occurred in the recent session was 0.37% while the dollar amount for the price change in DVA stock was $0.87.

DVA's industry and sector of operation?

The NYSE listed DVA is part of Medical - Care Facilities industry that operates in the broader Healthcare sector.

Who are the executives of DVA?

Christopher Michael Berry | Group Vice President & Chief Accounting Officer
Jeffrey Allen Giullian | Chief Medical Officer of Kidney Care
Partha Das | Chief Medical Officer of DaVita International
David Maughan | Chief Operating Officer of DaVita Kidney Care
Kathleen Alyce Waters | Chief Legal & Public Affairs Officer

How many employees does DVA have?

Number of DVA employees currently stands at 78000. DVA operates from 2000 16th Street, Denver, CO 80202, US.

Link for DVA official website?

Official Website of DVA is: https://www.davita.com

How do I contact DVA?

DVA could be contacted at phone #720 631 2100 and can also be accessed through its website. DVA operates from 2000 16th Street, Denver, CO 80202, US.

How many shares of DVA are traded daily?

The average number of DVA shares traded daily for last 3 months was 875.31K.

What is the market cap of DVA currently?

The market value of DVA currently stands at $15.17B with its latest stock price at $236.31